Keizo Koya, Senior VP, Drug Development at SYNTA PHARMACEUTICALS CORP (SNTA), sold 20,000 shares at $5.60 ($116K) on 2011-04-20, disclosed to the SEC on 2011-04-26.
Scheduled sale ($116k) by Senior VP, Drug Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.60 | 10,000 | $56K | 48.3% |
| 2 | $6.00 | 10,000 | $60K | 51.7% |
| Total | $5.80 avg | 20,000 | $116K | 100% |
| Filing → |
| SNTA | BUY | 2009-08-26 | $28K | — | Filing → |